Influenza News and Research

Latest Influenza News and Research

Study confirms safety of COVID-19 vaccination during pregnancy for infant neurodevelopment

A large cohort study in "JAMA Pediatrics" found no significant differences in neurodevelopmental rates between infants exposed to COVID-19 vaccines in-utero and those who were not, affirming the safety of maternal COVID-19 vaccination.

24 Jan 2024

Curcumin spray shows promise in fighting SARS-CoV-2 and flu viruses

A study in the Virology Journal reveals a curcumin-containing oro-nasal film spray with potential antiviral activity against SARS-CoV-2 and influenza viruses, boosting mucosal immunity without cytotoxic effects.

24 Jan 2024

UKHSA unveils groundbreaking Pathogen Genomics Strategy for pandemic preparedness

The UK Health Security Agency (UKHSA) has today published its Pathogen Genomics Strategy, laying out a 5 year plan for the organization's role in the wider delivery of pathogen genomics to prepare for and respond to infectious disease threats to public health.

24 Jan 2024

Prepared for the next virus pandemic: The APPEAL project

In collaboration with 12 partners from 6 countries, MatTek is establishing the Antivirus Pandemic Preparedness EuropeAn pLatform (APPEAL), a European research initiative aimed at enhancing preparedness for future pandemics.

From MatTek Corporation 24 Jan 2024

Long COVID's impact on cardiovascular health: what we do and do not know

Researchers review the cardiovascular effects of long COVID.

23 Jan 2024

Researchers develop a potential one-minute COVID-19 test inspired by bioluminescence

Cold, flu and COVID-19 season brings that now-familiar ritual: swab, wait, look at the result. But what if, instead of taking 15 minutes or more, a test could quickly determine whether you have COVID-19 with a glowing chemical?

18 Jan 2024

‘Emergency’ or not, covid is still killing people. Here’s what doctors advise to stay safe.

With around 20,000 people dying of covid in the United States since the start of October, and tens of thousands more abroad, the covid pandemic clearly isn't over.

18 Jan 2024

Study reveals intestinal helminth infection diminishes T cell response to COVID-19 mRNA vaccine

Study investigates the impact of helminth infection on COVID-19 mRNA vaccine efficacy, revealing that while antibody responses remain largely unaffected, T-cell responses are significantly impaired, particularly against Omicron variants.

17 Jan 2024

New vaccine turns preexisting flu immunity into COVID-19 weapon

After COVID vaccination, it usually takes weeks for our bodies to develop protective antibody responses.

17 Jan 2024

Large UK study highlights gaps in COVID-19 vaccine coverage

The first research study of the entire UK population highlights gaps in COVID-19 vaccine coverage. Between a third and a half of the populations of the four UK nations had not had the recommended number of COVID vaccinations and boosters by summer 2022.

16 Jan 2024

Paxlovid treatment in 20% of COVID-19 patients could avert 850,000 hospitalizations, save up to $170 billion

A study in the Emerging Infectious Diseases journal shows treating 20% of COVID-19 patients with Paxlovid could save up to 0.85 million lives and reduce the economic burden by US $170.17 billion in the US.

14 Jan 2024

Bivalent COVID-19 vaccines show higher effectiveness against thromboembolic events

Study finds bivalent mRNA COVID-19 vaccines are more effective than monovalent vaccines in preventing thromboembolic events in older adults and those with end-stage renal disease.

14 Jan 2024

Going green reduces COVID risk: Plant-based diets slash risk by up to 41%

Study finds plant-based diets reduce COVID-19 risk by 39-41% compared to meat-based diets, also associated with healthier BMI and lower obesity rates.

11 Jan 2024

CDC immunization schedule lacks clinician communication tools

In an editorial in the Annals of Internal Medicine, CUNY SPH Distinguished Lecturer Scott Ratzan, Senior Scholar Ken Rabin, and colleagues call for the Centers for Disease Control and Prevention (CDC) to "raise its persuasive communications game" on adult immunization to clinicians and the public.

11 Jan 2024

Influenza News and Research

Latest Influenza News and Research

Study confirms safety of COVID-19 vaccination during pregnancy for infant neurodevelopment

Curcumin spray shows promise in fighting SARS-CoV-2 and flu viruses

UKHSA unveils groundbreaking Pathogen Genomics Strategy for pandemic preparedness

Prepared for the next virus pandemic: The APPEAL project

Long COVID's impact on cardiovascular health: what we do and do not know

Researchers develop a potential one-minute COVID-19 test inspired by bioluminescence

‘Emergency’ or not, covid is still killing people. Here’s what doctors advise to stay safe.

Study reveals intestinal helminth infection diminishes T cell response to COVID-19 mRNA vaccine

New vaccine turns preexisting flu immunity into COVID-19 weapon

Large UK study highlights gaps in COVID-19 vaccine coverage

Paxlovid treatment in 20% of COVID-19 patients could avert 850,000 hospitalizations, save up to $170 billion

Bivalent COVID-19 vaccines show higher effectiveness against thromboembolic events

Going green reduces COVID risk: Plant-based diets slash risk by up to 41%

CDC immunization schedule lacks clinician communication tools

Blocking sugar molecules stops flu virus spread in mice

Nasal drops with IgA antibodies may protect against COVID-19 and future variants

Study finds Epstein-Barr virus T-cells prevalent in early multiple sclerosis

There’s a new covid-19 variant and cases are ticking up. What do you need to know?

Does SARS-CoV-2's ability to infect humans stem from its evolutionary past?

UKHSA urges eligible groups to get vaccinated against flu and COVID-19

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Influenza News and Research

Latest Influenza News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in